http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001503769-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 1997-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001503769-A |
| titleOfInvention | Substituted tetrahydro-1,3,5-triazine-2 [1H] -thione as anti-atherosclerosis drug |
| abstract | (57) [Summary] The present invention provides a compound of the formula (1) having the following structure, which is useful as an anti-atherosclerosis drug: [Wherein, R 1 , R 2 , R 3 , R 4 and R 5 each independently represent hydrogen, halogen, alkyl, cycloalkyl, alkenyl, alkynyl, phenylalkyl, alkoxy, aryloxy, fluoroalkoxy, trialkoxy, fluoromethyl, alkylthio, alkylsulfonyl, -SCH 3, nitro, alkylamino or dialkylamino; R 6 is hydrogen, alkyl, cycloalkyl, or arylalkyl; R 7 is alkyl, the compound represented by cycloalkyl or arylalkyl Or a pharmaceutically acceptable salt thereof. |
| priorityDate | 1996-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.